share_log

Everjoy Health Group's (SZSE:002162) Performance Is Even Better Than Its Earnings Suggest

Everjoy Health Group's (SZSE:002162) Performance Is Even Better Than Its Earnings Suggest

Everjoy Health Group(深圳證券交易所:002162)的表現甚至好於其收益預期
Simply Wall St ·  05/02 18:26

The subdued stock price reaction suggests that Everjoy Health Group Co., Ltd.'s (SZSE:002162) strong earnings didn't offer any surprises. We think that investors have missed some encouraging factors underlying the profit figures.

疲軟的股價反應表明,Everjoy Health Group Co., Ltd.s(深圳證券交易所:002162)強勁的收益並沒有帶來任何意外。我們認爲,投資者錯過了利潤數據背後的一些令人鼓舞的因素。

earnings-and-revenue-history
SZSE:002162 Earnings and Revenue History May 2nd 2024
SZSE: 002162 收益和收入歷史記錄 2024 年 5 月 2 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

To properly understand Everjoy Health Group's profit results, we need to consider the CN¥15m expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect Everjoy Health Group to produce a higher profit next year, all else being equal.

爲了正確了解Everjoy Health Group的利潤業績,我們需要考慮因不尋常項目而產生的1500萬元人民幣支出。儘管由於不尋常項目而產生的扣除首先令人失望,但有一線希望。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。鑑於這些單列項目被認爲不尋常,這並不奇怪。假設這些不尋常的支出不會再次出現,因此,我們預計Everjoy Health Group在其他條件相同的情況下,明年將實現更高的利潤。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Everjoy Health Group.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對Everjoy Health Group的資產負債表分析。

Our Take On Everjoy Health Group's Profit Performance

我們對Everjoy Health 集團盈利表現的看法

Because unusual items detracted from Everjoy Health Group's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Everjoy Health Group's earnings potential is at least as good as it seems, and maybe even better! And it's also positive that the company showed enough improvement to book a profit this year, after losing money last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. For example, we've found that Everjoy Health Group has 2 warning signs (1 can't be ignored!) that deserve your attention before going any further with your analysis.

由於不尋常的項目削弱了Everjoy Health Group去年的收益,你可能會爭辯說,我們可以預期本季度的業績會有所改善。因此,我們認爲Everjoy Health Group的盈利潛力至少和看起來一樣好,甚至可能更好!在去年虧損之後,該公司表現出了足夠的改善,今年實現了盈利,這也是一個積極的因素。歸根結底,如果你想正確地了解公司,必須考慮的不僅僅是上述因素。有鑑於此,如果你想對公司進行更多分析,了解所涉及的風險至關重要。例如,我們發現 Everjoy Health Group 有 2 個警告信號(1 個不容忽視!)在進行進一步分析之前,這值得你注意。

Today we've zoomed in on a single data point to better understand the nature of Everjoy Health Group's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

今天,我們放大了單個數據點,以更好地了解Everjoy Health Group利潤的性質。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論